InterHealth acquired by private equity firm

BENICIA, CALIF. — InterHealth Nutraceuticals, Inc., an ingredient manufacturer, has been acquired by Kainos Capital, Dallas, a private equity firm that focuses on the food and consumer markets. Terms of the acquisition were not disclosed.

“We believe InterHealth is an outstanding organization, led by a management team with a strong commitment to science-based product development and unwavering quality and customer service,” said Andrew Rosen, Managing Partner of Kainos Capital.  “InterHealth’s portfolio of branded functional ingredients is supported by strong clinical data and addresses functional end markets that have compelling and enduring growth dynamics.”

Some ingredients manufactured by InterHealth include Super Citrimax, for weight management, and UC-II, for joint health.

“InterHealth’s success has been marked by its unique, high quality ingredients, extensive research program, outstanding customer service and powerful co-branding strategy that delivers relevant and differentiated concepts to its customers,” said Paul Dijkstra, chief executive officer of InterHealth. “Kainos brings deep experience in the nutritional ingredient sector which will assist InterHealth through its next phase of growth.”